Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Endostar Combined With Docetaxel and Cisplatin on the Angiogenesis of Advanced Non-small Cell Lung Cancer

NCT00657423 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT00657423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00657423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Endostar Combined With Docetaxel and Cisplatin on the Angiogenesis of Advanced Non-small Cell Lung Cancer
Lead sponsor
Xijing Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2008
Completion date
April 30, 2009
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms